Oxford Biomedica (LON:OXB) Reaches New 1-Year High – Here’s What Happened

Shares of Oxford Biomedica plc (LON:OXB) reached a new 52-week high on Tuesday . The company traded as high as GBX 455 ($5.66) and last traded at GBX 444 ($5.52), with a volume of 467163 shares trading hands. The stock had previously closed at GBX 416 ($5.18).

Oxford Biomedica Trading Up 6.7 %

The company has a market cap of £467.80 million, a price-to-earnings ratio of -308.33 and a beta of 1.09. The firm has a fifty day moving average price of GBX 419.45 and a 200 day moving average price of GBX 386.89. The company has a debt-to-equity ratio of 154.88, a quick ratio of 1.67 and a current ratio of 2.35.

Oxford Biomedica Company Profile

Oxford Biomedica (LSE: OXB) is a quality and innovation-led cell and gene therapy CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world.

One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.